Tilray® Announces Support of Two New Clinical Research Studies in Australia and Canada
Tilray cannabis products will be used to support the Murdoch Children’s Research Institute led pilot study to evaluate the feasibility…
Pharmaceuticals, Biotechnology and Life Sciences
Tilray cannabis products will be used to support the Murdoch Children’s Research Institute led pilot study to evaluate the feasibility…
$12 million in extension funding announced Karuna awarded U.S. Patent covering lead product candidate, KarXT BOSTON–(BUSINESS WIRE)–Karuna Therapeutics, Inc. (“Karuna”)…
SKOKIE, Ill.–(BUSINESS WIRE)–Exicure, Inc. (OTCQB: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs,…
KEYTRUDA is First Anti-PD-1 Therapy to be Approved in Multiple Tumor Types in China KENILWORTH, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24MRK&src=ctag" target="_blank"gt;$MRKlt;/agt; lt;a…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…
Designation Based on Phase 2 SPRINT Trial in Pediatric Patients with NF1 Plexiform Neurofibromas Selumetinib Is a MEK 1/2 Inhibitor…
Two posters are being presented at the AACR Annual Meeting in Atlanta, GeorgiaExicure’s TLR9 agonist shows activation of NK cells…
Pharma player Lupin Limited has appointed Christine Mundkur as an Independent Director with immediate effect, the company said Monday, recent CEO of Impopharma Inc.
DUBLIN–(BUSINESS WIRE)–The “Global Industrial Microbiological QC Market: Focus on Technology Trends, Application, Regulatory Framework, and Competitive Mapping Analysis and Forecast:…
DUBLIN–(BUSINESS WIRE)–The “Primary Progressive Multiple Sclerosis (PPMS) – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The…